Hi HenWin,
Glad you found your way here from the other thread. I couldn't say too much on the MSB thread for fear of being moderated for cross-promotion. I sincerely hope that the research you do on EMtinB gives you some good hope for the future.
As the report says, not only does EmtinB significantly increases the myelin formation around the nerve cells, but in its higher doses actively promotes regeneration.
Another avenue for research would be peptide based therapies which are moving ahead in leaps and bounds. PYC is one that is worth reading up on. Their first proving therapies are for optical conditions, but their proprietory platforms also include neurodegenerative diseases that are yet to be announced. I know they have done initial work on DMD (Duchene's Muscular Dystrophy) which my 2 nephews in the UK live with. Like MS, a very debilitating condition.
Good luck.
Malown1
- Forums
- ASX - By Stock
- NSB
- Ann: Full Report from Multiple Sclerosis Study
Ann: Full Report from Multiple Sclerosis Study, page-20
Featured News
Add NSB (ASX) to my watchlist
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.639M |
Open | High | Low | Value | Volume |
3.9¢ | 3.9¢ | 3.9¢ | $3 | 76 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 40000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | 0.039 |
1 | 100000 | 0.038 |
3 | 301850 | 0.037 |
2 | 225000 | 0.036 |
1 | 200000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 40000 | 1 |
0.045 | 20000 | 1 |
0.046 | 50000 | 1 |
0.050 | 85611 | 4 |
0.051 | 83976 | 2 |
Last trade - 13.24pm 06/09/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |